| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $53.5M | — | -6.6% |
| Cost of Revenue | $12.3M | — | +61.2% |
| R&D Expense | $14.8M | — | +51.8% |
| SG&A Expense | $30.4M | — | +18.2% |
| Operating Income | -$4.7M | — | -134.7% |
| Pre-tax Income | -$8.9M | — | -246.1% |
| Income Tax | $126K | — | — |
| Net Income | -$9.1M | — | -248.1% |
| EPS (Basic) | -$0.03 | — | -200.0% |
| EPS (Diluted) | -$0.03 | — | -200.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $162.6M | -12.0% | +43.5% |
| Accounts Receivable | $62.5M | +33.0% | +1.6% |
| Inventory | $13.0M | -16.7% | -34.1% |
| Current Assets | $243.5M | -3.7% | +19.5% |
| Total Assets | $362.5M | -3.7% | +16.9% |
| Current Liabilities | $173.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$21.2M | — | -56.1% |
| Capital Expenditures | $62K | — | +244.4% |
| Investing Cash Flow | -$62K | — | -140.3% |
| Financing Cash Flow | -$926K | — | -101.2% |
| Free Cash Flow | -$21.3M | — | -56.3% |
| +90.6% |
| Long-term Debt | $48.9M | +1.3% | +5.1% |
| Total Liabilities | $335.1M | -2.6% | +17.3% |
| Stockholders' Equity | $27.4M | -16.1% | +11.4% |